BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

8.48

-0.02 (-0.24%)

At close: Mar 6, 2026, 4:00 PM EST

8.60

+0.12 (1.42%)

After-hours: Mar 6, 2026, 7:37 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology (Startups)	874.84M	450.71M	331.41M	270.83M	157.17M
Biotechnology (Startups) Growth	94.10%	36.00%	22.37%	72.31%	782.38%
Total	874.84M	450.71M	331.41M	270.83M	157.17M
Total Growth	94.10%	36.00%	22.37%	72.31%	782.38%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	548.78M	385.96M	288.36M	-	-
United States Growth	42.19%	33.85%	-	-	-
Outside United States	53.06M	51.70M	37.63M	-	-
Outside United States Growth	2.63%	37.39%	-	-	-
Unallocated	273.00M	13.05M	5.42M	-	-
Unallocated Growth	1991.62%	140.72%	-	-	-
Total	874.84M	450.71M	331.41M	-	-
Total Growth	94.10%	36.00%	-	-	-

Source: S&P Global Market Intelligence.